|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q87661010
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010858.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q87661010
|
|
024
|
|
|
‡a
0000-0003-4308-856X
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q87661010
|
|
100
|
0 |
|
‡a
Sarah J Stock
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Sarah J Stock
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis
|
|
670
|
|
|
‡a
Author's Barriers to progress in pregnancy research: How can we break through?
|
|
670
|
|
|
‡a
Author's Caesarean birth and risk of subsequent preterm birth: a retrospective cohort study
|
|
670
|
|
|
‡a
Author's Cathelicidins and the Onset of Labour
|
|
670
|
|
|
‡a
Author's Cervical epithelial damage promotes Ureaplasma parvum ascending infection, intrauterine inflammation and preterm birth induction in mice
|
|
670
|
|
|
‡a
Author's COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data
|
|
670
|
|
|
‡a
Author's Defining Abnormal Fetal Growth and Perinatal Risk: Population or Customized Standards?
|
|
670
|
|
|
‡a
Author's Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth
|
|
670
|
|
|
‡a
Author's Feasibility and design of a trial regarding the optimal mode of delivery for preterm birth: the CASSAVA multiple methods study
|
|
670
|
|
|
‡a
Author's Gestational age at delivery of twins and perinatal outcomes: a cohort study in Aberdeen, Scotland
|
|
670
|
|
|
‡a
Author's HPV infection and pre-term birth: a data-linkage study using Scottish Health Data
|
|
670
|
|
|
‡a
Author's Informing prevention of stillbirth and preterm birth in Malawi: development of a minimum dataset for health facilities participating in the DIPLOMATIC collaboration
|
|
670
|
|
|
‡a
Author's Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
|
|
670
|
|
|
‡a
Author's Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data
|
|
670
|
|
|
‡a
Author's Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.
|
|
670
|
|
|
‡a
Author's Long term cognitive outcomes of early term
|
|
670
|
|
|
‡a
Author's Long term cognitive outcomes of early term (37-38 weeks) and late preterm (34-36 weeks) births: A systematic review.
|
|
670
|
|
|
‡a
Author's Low-dose aspirin for the prevention of preterm birth: More questions than answers
|
|
670
|
|
|
‡a
Author's Maternal smoking and preterm birth: An unresolved health challenge
|
|
670
|
|
|
‡a
Author's Medicines in pregnancy
|
|
670
|
|
|
‡a
Author's Open randomised trial of the
|
|
670
|
|
|
‡a
Author's Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocol
|
|
670
|
|
|
‡a
Author's Placental hormone profiles as predictors of preterm birth in twin pregnancy: A prospective cohort study
|
|
670
|
|
|
‡a
Author's Postal recruitment for genetic studies of preterm birth: A feasibility study
|
|
670
|
|
|
‡a
Author's Quantitative fibronectin to help decision-making in women with symptoms of preterm labour
|
|
670
|
|
|
‡a
Author's Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis.
|
|
670
|
|
|
‡a
Author's Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study.
|
|
670
|
|
|
‡a
Author's Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection
|
|
909
|
|
|
‡a
(orcid) 000000034308856x
‡9
1
|
|
919
|
|
|
‡a
caesareanbirthandriskofsubsequentpretermbirtharetrospectivecohortstudy
‡A
Caesarean birth and risk of subsequent preterm birth: a retrospective cohort study
‡9
1
|
|
919
|
|
|
‡a
cervicalepithelialdamagepromotesureaplasmaparvumascendinginfectionintrauterineinflammationandpretermbirthinductioninmice
‡A
Cervical epithelial damage promotes Ureaplasma parvum ascending infection, intrauterine inflammation and preterm birth induction in mice
‡9
1
|
|
919
|
|
|
‡a
covid19inpregnancyinscotlandcopsprotocolforanobservationalstudyusinglinkedscottishnationaldata
‡A
COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data
‡9
1
|
|
919
|
|
|
‡a
definingabnormalfetalgrowthandperinatalriskpopulationorcustomizedstandards
‡A
Defining Abnormal Fetal Growth and Perinatal Risk: Population or Customized Standards?
‡9
1
|
|
919
|
|
|
‡a
directonswabmetabolicprofilingofvaginalmicrobiomehostinteractionsduringpregnancyandpretermbirth
‡A
Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth
‡9
1
|
|
919
|
|
|
‡a
feasibilityanddesignofatrialregardingtheoptimalmodeofdeliveryforpretermbirththecassavamultiplemethodsstudy
‡A
Feasibility and design of a trial regarding the optimal mode of delivery for preterm birth: the CASSAVA multiple methods study
‡9
1
|
|
919
|
|
|
‡a
gestationalageatdeliveryoftwinsandperinataloutcomesacohortstudyinaberdeenscotland
‡A
Gestational age at delivery of twins and perinatal outcomes: a cohort study in Aberdeen, Scotland
‡9
1
|
|
919
|
|
|
‡a
hpvinfectionandpretermbirthadatalinkagestudyusingscottishhealthdata
‡A
HPV infection and pre-term birth: a data-linkage study using Scottish Health Data
‡9
1
|
|
919
|
|
|
‡a
informingpreventionofstillbirthandpretermbirthinmalawidevelopmentofaminimumdatasetforhealthfacilitiesparticipatinginthediplomaticcollaboration
‡A
Informing prevention of stillbirth and preterm birth in Malawi: development of a minimum dataset for health facilities participating in the DIPLOMATIC collaboration
‡9
1
|
|
919
|
|
|
‡a
interimfindingsfrom1dosemasscovid19vaccinationrolloutandcovid19hospitaladmissionsinscotlandanationalprospectivecohortstudy
‡A
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
‡9
1
|
|
919
|
|
|
‡a
investigatingtheuptakeeffectivenessandsafetyofcovid19vaccinesprotocolforanobservationalstudyusinglinkeduknationaldata
‡A
Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data
‡9
1
|
|
919
|
|
|
‡a
isthe1urinaryalbumincreatinineratioacrinwomenwithsuspectedpreeclampsiaaprognosticfactorformaternalandneonataladverseoutcomearetrospectivecohortstudy
‡A
Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.
‡9
1
|
|
919
|
|
|
‡a
longtermcognitiveoutcomesofearlyterm
‡A
Long term cognitive outcomes of early term
‡9
1
|
|
919
|
|
|
‡a
longtermcognitiveoutcomesofearlyterm3738weeksandlatepreterm3436weeksbirthsasystematicreview
‡A
Long term cognitive outcomes of early term (37-38 weeks) and late preterm (34-36 weeks) births: A systematic review.
‡9
1
|
|
919
|
|
|
‡a
lowdoseaspirinforthepreventionofpretermbirthmorequestionsthananswers
‡A
Low-dose aspirin for the prevention of preterm birth: More questions than answers
‡9
1
|
|
919
|
|
|
‡a
maternalsmokingandpretermbirthanunresolvedhealthchallenge
‡A
Maternal smoking and preterm birth: An unresolved health challenge
‡9
1
|
|
919
|
|
|
‡a
medicinesinpregnancy
‡A
Medicines in pregnancy
‡9
1
|
|
919
|
|
|
‡a
openrandomisedtrialofthe
‡A
Open randomised trial of the
‡9
1
|
|
919
|
|
|
‡a
openrandomisedtrialofthearabinpessarytopreventpretermbirthintwinpregnancywithhealtheconomicsandacceptabilitystoppit2astudyprotocol
‡A
Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocol
‡9
1
|
|
919
|
|
|
‡a
placentalhormoneprofilesaspredictorsofpretermbirthintwinpregnancyaprospectivecohortstudy
‡A
Placental hormone profiles as predictors of preterm birth in twin pregnancy: A prospective cohort study
‡9
1
|
|
919
|
|
|
‡a
postalrecruitmentforgeneticstudiesofpretermbirthafeasibilitystudy
‡A
Postal recruitment for genetic studies of preterm birth: A feasibility study
‡9
1
|
|
919
|
|
|
‡a
quantitativefibronectintohelpdecisionmakinginwomenwithsymptomsofpretermlabour
‡A
Quantitative fibronectin to help decision-making in women with symptoms of preterm labour
‡9
1
|
|
919
|
|
|
‡a
quantitativefibronectintohelpdecisionmakinginwomenwithsymptomsofpretermlabourquidspart1individualparticipantdatametaanalysisandhealtheconomicanalysis
‡A
Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis.
‡9
1
|
|
919
|
|
|
‡a
studyprotocolquantitativefibronectintohelpdecisionmakinginwomenwithsymptomsofpretermlabourquidspart2ukprospectivecohortstudy
‡A
Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study.
‡9
1
|
|
919
|
|
|
‡a
sulphadoxinepyrimethamineplusazithromycinmayimprovebirthoutcomesthroughimpactsoninflammationandplacentalangiogenesisindependentofmalarialinfection
‡A
Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection
‡9
1
|
|
919
|
|
|
‡a
cathelicidinsandtheonsetoflabour
‡A
Cathelicidins and the Onset of Labour
‡9
1
|
|
919
|
|
|
‡a
evaluationofthebenefitsandharmsofantenatalcorticosteroidtreatmentforwomenatriskofimminentpretermbirthorpriortoelectivecaesareansectionstudyprotocolforanindividualparticipantdatametaanalysis
‡A
An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis
‡9
1
|
|
919
|
|
|
‡a
barrierstoprogressinpregnancyresearchhowcanwebreakthrough
‡A
Barriers to progress in pregnancy research: How can we break through?
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000063988811
|
|
996
|
|
|
‡2
RERO|A003866053
|
|
996
|
|
|
‡2
DNB|1274342465
|
|
996
|
|
|
‡2
NTA|321449134
|
|
996
|
|
|
‡2
DNB|1061988430
|
|
996
|
|
|
‡2
NLA|000036041454
|
|
996
|
|
|
‡2
BIBSYS|1020417
|
|
996
|
|
|
‡2
LC|no2003071001
|
|
996
|
|
|
‡2
J9U|987007285895005171
|
|
996
|
|
|
‡2
LIH|LNB:_v__c_1;=B_q_
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
